Clonidine in abstinence reactions: basic mechanisms.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000818:Animals; D001008:Anxiety Disorders / Q000188:drug therapy; D001341:Autonomic Nervous System / Q000503:physiopathology; D002490:Central Nervous System / Q000502:physiology; D003000:Clonidine / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D000431:Ethanol / Q000009:adverse effects; D000882:Haplorhini; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008125:Locus Coeruleus / Q000502:physiology; D001523:Mental Disorders / Q000188:drug therapy*; D009294:Narcotics / Q000009:adverse effects; D009638:Norepinephrine / Q000502:physiology; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy; D012907:Smoking; D013315:Stress, Psychological / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D005879:Tourette Syndrome / Q000188:drug therapy
D000316:Adrenergic alpha-Agonists; D009294:Narcotics; D011942:Receptors, Adrenergic, alpha; D000431:Ethanol; D003000:Clonidine; D009638:Norepinephrine